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Summary
Aging is the largest risk factor for cardiovascular disease, yet the molecular mecha-
nisms underlying vascular aging remain unclear. Mitochondrial DNA (mtDNA) dam-
age is linked to aging, but whether mtDNA damage or mitochondrial dysfunction is
present and directly promotes vascular aging is unknown. Furthermore, mechanistic
studies in mice are severely hampered by long study times and lack of sensitive,
repeatable and reproducible parameters of arterial aging at standardized early time
points. We examined the time course of multiple invasive and noninvasive arterial
physiological parameters and structural changes of arterial aging in mice, how aging
affects vessel mitochondrial function, and the effects of gain or loss of mitochon-
drial function on vascular aging. Vascular aging was first detected by 44 weeks (wk)
of age, with reduced carotid compliance and distensibility, increased b-stiffness
index and increased aortic pulse wave velocity (PWV). Aortic collagen content and
elastin breaks also increased at 44 wk. Arterial mtDNA copy number (mtCN) and
the mtCN-regulatory proteins TFAM, PGC1a and Twinkle were reduced by 44 wk,
associated with reduced mitochondrial respiration. Overexpression of the mitochon-
drial helicase Twinkle (Tw+) increased mtCN and improved mitochondrial respiration
in arteries, and delayed physiological and structural aging in all parameters studied.
Conversely, mice with defective mitochondrial polymerase-gamma (PolG) and
reduced mtDNA integrity demonstrated accelerated vascular aging. Our study iden-
tifies multiple early and reproducible parameters for assessing vascular aging in
mice. Arterial mitochondrial respiration reduces markedly with age, and reduced
mtDNA integrity and mitochondrial function directly promote vascular aging.
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1 | INTRODUCTION
Aging of the large conduit arteries is a major cause of morbidity and
mortality, contributing to hypertension (high blood pressure)
and stroke. Arterial aging is associated with multiple structural and
functional changes, including vessel dilatation and wall thickening,
loss of vascular smooth muscle cells (VSMCs) and elastin, deposition
of collagen, endothelial dysfunction and low-grade inflammation. In
turn, these changes (which are present in both humans (Wang et al.,
2007) and rodents (Wang et al., 2006)) result in vessel stiffening.
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Vascular stiffening may also be a consequence of hypertension, in
part because of stress-induced matrix synthesis by mechanosensitive
cells, resulting in a positive feedback loop (reviewed in Humphrey,
Harrison, Figueroa, Lacolley & Laurent, 2016).
Large artery aging has been demonstrated extensively in humans,
and several invasive and noninvasive parameters of vascular stiffness
can reliably predict cardiovascular events (reviewed in Vlachopoulos,
Aznaouridis & Stefanadis, 2010). However, dissecting the molecular
mechanisms underlying vascular aging requires studies in animal
models, and similar studies in rodents are more difficult to perform.
Currently, it is unclear what the earliest time points that constitute
vascular aging in laboratory mice are, which physiological measures
of large artery stiffness correspond most closely to humans, and
whether similar processes underlie changes in mechanical properties
in mouse and human arteries. Aging research is time-consuming and
expensive because of the long time courses needed. Therefore, iden-
tifying the earliest time points that show the most sensitive and
reproducible changes and parameters is crucial in obtaining scientific
consensus for mouse models of vascular aging.
Mitochondria contain multiple copies of mitochondrial DNA
(mtDNA) that encode ribosomal and transfer RNAs and many essential
proteins required for oxidative phosphorylation. Loss of mtDNA integ-
rity by both altered mitochondrial DNA copy number (mtCN) and
increased mutations is implicated in cellular dysfunction with aging
(Szklarczyk, Nooteboom & Osiewacz, 2014). Reactive oxygen species
(ROS), many of which are generated by mitochondria, also increase
with age. However, the role of mitochondria in aging may extend
beyond ROS, and it is unclear whether decreased mitochondrial func-
tion promotes vascular aging directly or is just a consequence of aging.
We examined multiple parameters of vascular function, histologi-
cal markers, and markers of mitochondrial damage and function dur-
ing normal vascular aging, and the effects of reducing or augmenting
mitochondrial function on the onset and progression of vascular
aging. We identify early, standardized time points and reproducible
physiological parameters for vascular aging studies in mice. Vascular
aging begins at far earlier time points than previously described in
mice, with compliance, distensibility, stiffness and pulse wave velocity
(PWV) being the best discriminators for normal aging and manipula-
tions. mtCN and mitochondrial respiratory function are reduced when
functional and structural manifestations of vascular aging begin. Res-
cue of the mtCN deficit observed in normal aging improves mitochon-
drial respiration and delays all parameters of vascular aging, while
reduced mtDNA integrity accelerates vascular aging. Together these
data highlight the direct role of mtDNA-mediated mitochondrial dys-
function in the progression of vascular aging.
2 | RESULTS
2.1 | Physiological markers of normal aging in mice
The hallmark of vascular aging is vascular stiffening, predominantly
due to loss of elastin and elevated collagen deposition. Vessel stiff-
ening is challenging to measure in mice, and there is a lack of
consensus about the most sensitive and discriminatory parameters.
We analysed multiple indices of stiffness of the common carotid
artery and aorta during normal mouse aging, including compliance
(change in volume (DV)/change in pressure (DP)), distensibility
(change in arterial diameter (DD) or circumferential area in systole
and diastole) and b-stiffness index (DP per DD). DV, DD and Doppler
flow velocities were assessed by imaging the common carotid artery
(Figure S1) and DP by intra-arterial blood pressure measurement.
PWV is considered the gold standard measure of vascular stiffness
in humans (Vlachopoulos et al., 2010) and was measured in mice by
simultaneous measurement of aortic pressure at two different
anatomical sites (Figure S2). To determine the earliest time points
that demonstrate changes in vascular physiological parameters, we
examined wild-type (WT) C57BL/6J mice at 8, 22, 44 and 72 wk of
age. We did not observe any differences in any parameter between
male and female mice, and therefore, both sexes were used. Mean
systolic and diastolic blood pressure did not change between 8 and
72 wk (Figure S3a,b). Pulse pressure was similar from 8 to 44 wk,
but increased significantly by 24% at 72 wk (Figures 1a and S3c),
while heart rate did not change at any age (Figure 1b). In contrast,
aortic PWV was significantly elevated at 44 wk (Figure 1c). Similarly,
carotid arterial compliance and distensibility were significantly
reduced by 44 wk, with a concomitant increase in b-stiffness index
at the same age (Figure 1d–f). Systolic and diastolic Doppler flow
velocities were also elevated at 72 wk by 36% and 37%, respectively
(Figure S3d,e).
2.2 | Changes in vascular structure in normal
vascular aging
Vascular aging in humans is associated with reduced VSMC cellular-
ity, elastin breaks, increased collagen deposition, and intimal, medial
and adventitial thickening. However, it is unclear whether these
changes occur in mice, and whether they precede, accompany or fol-
low the functional effects of aging. Medial collagen content
increased significantly by 1.6-fold at 44 wk and remained elevated
at 72 wk, with a characteristic periadventitial accumulation (Fig-
ure 2a–b). Elastin breaks increased 4.3-fold over the same time
frame, which increased a further 1.2-fold by 72 wk (Figure 2a,c).
Medial cell number was unchanged between 8 and 72 wk, but med-
ial cellularity decreased 1.4-fold between 44 and 72 wk, while over-
all aortic thickness increased 1.3-fold at 22 wk, but did not change
thereafter (Figure 2a,d,e). Inflammation markers examined by
immunohistochemistry showed that the percentage of IL-1b-positive
cells was unchanged from 8 to 44 wk, but increased 1.5-fold at
72 wk. There was no consistent trend in VCAM-1 expression (Fig-
ure S4), and macrophages were infrequent (<1% cells).
2.3 | Effects of aging on mtCN and mitochondrial
respiration
Cells contain many copies of the mitochondrial genome, and
although mtCN declines with age in some cells (Mengel-From et al.,
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2014), the rate of decline and the relationship between mtCN and
mitochondrial respiration vary markedly between tissues (Wachs-
muth, Hubner, Li, Madea & Stoneking, 2016). We examined mtCN
relative to nuclear DNA in aortas from mice aged 8–72 wk. Relative
aortic mtCN was unchanged between 8 and 22 wk, but decreased
significantly at 44 and 72 wk (Figure 3a). mtDNA integrity was
reduced at 22 wk and remained reduced thereafter, indicating rela-
tively increased mtDNA lesions (Figures 3b and S5a). This mtDNA
damage was not due to the presence of the mouse equivalent of the
human 4977-bp “common deletion,” as this was unchanged across
all ages (Figure S5b).
mtDNA synthesis is directly regulated by a number of proteins,
including the mitochondrial transcription factor A (TFAM), mitochon-
drial helicase Twinkle and peroxisome proliferator-activated recep-
tor-gamma coactivator 1-alpha (PGC1a), which is an upstream
mediator of TFAM expression and mitochondrial mass. Reductions in
mtCN at 44 wk were mirrored by marked reductions in Twinkle,
TFAM and PGC1a protein expression (Figure 3c–g), and similar
reductions in Twinkle and TFAM mRNA at 44 wk (Figure S5c,d).
mtDNA encodes many of the mitochondrial electron transport chain
complex proteins, and there was a significant decline in complexes II,
IV and V at 44 wk with recovery of complex II at 72 wk (Figure 3h).
To determine how changes in mtCN and complex expression affect
mitochondrial function, we measured mitochondrial respiration in
intact aorta tissue using a Seahorse XFe24 Bioanalyzer at baseline
and after inhibition of specific complexes with oligomycin A (com-
plex V) or rotenone/antimycin A (complex I/III), or uncoupling with
carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP). Base-
line oxygen consumption rate (OCR) was unchanged between 8 and
22 wk, but was reduced at 44 and 72 wk (Figure 3i,j). In contrast,
extracellular acidification rate (ECAR), a measure of glycolysis, was
unchanged between 8 and 72 wk (Figure S5e,f). These data show
that despite a possible compensatory rise in the expression of
PGC1a, TFAM and Twinkle (and a rise in nuclear-encoded complex
II) at 72 wk, this was not sufficient to rescue mtCN and mitochon-
drial respiration at 72 wk.
2.4 | Effects of augmented mitochondrial
respiration on vascular aging markers
Our data show that physiological and structural markers of vascular
aging can be detected early in mice, and are most marked at 44 wk
of age, with some additional changes between 44 and 72 wk. mtCN
and mitochondrial respiration decline over the same ages, with
reduced expression of mtCN-regulatory proteins and mitochondrial
complexes at 44 wk. However, it is unknown whether the decline in
mtCN and reduced mitochondrial function are a cause or a conse-
quence of vascular aging, or whether mtCN itself has direct effects
on mitochondrial function. We therefore examined markers of vascu-
lar aging in gain- and loss-of-function mice that have increased
mtCN or mtDNA damage, respectively.
We used mice overexpressing the mitochondrial helicase Twinkle
to determine whether augmenting mtCN and mitochondrial respira-
tion delays vascular aging. The nuclear-encoded mitochondrial heli-
case Twinkle, the mitochondrial polymerase-gamma (PolG) and
mitochondrial single-strand DNA binding proteins (mtSSB) form the
mtDNA replisome machinery. Twinkle unwinds short stretches of
dsDNA in the 50–30 direction in preparation for mtDNA replication,
and alterations in Twinkle expression lead to changes in mtCN (Jemt
et al., 2011). Twinkle-/- mice show multiple mtDNA deletions and
develop progressive respiratory dysfunction and chronic late-onset
mitochondrial disease (Tyynismaa et al., 2005). In contrast, mice
overexpressing Twinkle show increased mtCN (Tyynismaa et al.,
2004), which could potentially increase mitochondrial respiration.
Indeed, Twinkle overexpression can rescue single-nucleotide variants
and replication stalling of mtDNA, reduce ROS-induced apoptosis
and improve tissue function (Pohjoismaki et al., 2013), with no
change in ROS (Yu et al., 2017). We used mice heterozygous for
overexpression of the WT Twinkle transgene (TwWT+; denoted here-
after as Tw+), as very high mtCN in homozygous Twinkle mice can
result in respiratory chain deficiency (Ylikallio, Tyynismaa, Tsutsui,
Ide & Suomalainen, 2010).
Tw+ mice had increased Twinkle mRNA and Twinkle protein
expression in aortas compared to WT mice (Figure 4a–c), with
increased mtCN evident up to late time points (Figure 4d). Although
only complex IV protein levels were significantly increased in Tw+ mice
(a) (b)
(c) (d)
(e) (f)
F IGURE 1 Functional evidence that mice develop vascular
stiffness by 44 wk of age. (a–f) Pulse pressure, heart rate, aortic
pulse wave velocity (PWV), carotid artery compliance, carotid artery
distensibility and carotid artery b-stiffness index in WT mice aged
8–72 wk. Data are means  SEM. *p < .05 using ANOVA with
Tukey post-test (n = 10–17)
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(Figure 4e,f), Tw+ mice showed a marked increase in aortic mitochon-
drial respiration at baseline and after FCCP at 44 wk (Figure 4g,h).
As vascular aging markers changed significantly between 22 and
72 wk in WT mice (Figures 1 and 2), we examined parameters of
vascular aging in Tw+ vs. WT mice aged 22–72 wk. Data are pre-
sented with WT and Tw+ time courses adjacent to identify accelera-
tion or delay of vascular aging (Figure 5). Pulse pressure increased in
WT mice at 72 wk, but was unchanged in Tw+ mice, with no differ-
ences in heart rate in either group (Figure 5a,b). Carotid artery com-
pliance and distensibility declined while PWV and stiffness increased
at 44 wk in WT mice; however, these changes were all delayed until
72 wk in Tw+ mice (Figure 5c–f). When comparing directly to WT,
b-stiffness, distensibility and systolic and diastolic Doppler velocity
were all significantly improved at 44 wk in Tw+ mice. Collagen con-
tent peaked by 44 wk in WT mice, whereas peak collagen content
was delayed to 72 wk in Tw+ mice (Figure 5g). Increased elastin
breaks were seen at 44 wk in WT mice, but delayed in Tw+ mice to
72 wk (Figure 5h). These data demonstrate that augmenting mtCN
enhances mitochondrial respiration and delays both physiological and
structural changes associated with vascular aging.
To better understand how Twinkle expression delays vascular
aging, we examined regulators associated with mtCN, mitochondrial
mass and autophagy. Tw+ mice showed increased TFAM expression
at 44 wk compared to WT, but this difference was no longer present
at 72 wk (Figure S6a). PGC1a levels were higher in Tw+ mice at
72 wk compared to WT, consistent with a potential increase in mito-
chondrial biogenesis in Tw+ mice (Figure S6b). Furthermore, levels of
the autophagy marker p62 were reduced in Tw+ mice at 44 wk, but
similar to WT at 72 wk (Figure S6c).
2.5 | Effects of PolG mutation on mitochondrial
respiration and vascular aging markers
To confirm that changes to mtDNA can directly promote vascular
aging, we examined vascular aging markers in mice with compro-
mised mtDNA integrity. PolGmut/mut mice (hereafter denoted as PolG
mice) have an induced homozygous aspartic acid to alanine mutation
of the exonuclease domain of the nuclear-encoded mitochondrial
PolG. The resulting defect in proofreading function results in wide-
spread mtDNA point mutations and deletions (Trifunovic et al.,
(a)
(b) (c)
(d) (e)
F IGURE 2 Structural evidence that
mice develop increased collagen, elastin
breaks, reduced cellularity and vessel
thickening by 44 wk of age. (a)
Representative images of aorta sections
stained with Sirius Red, Verhoeff–van
Gieson (VVG) or haematoxylin and eosin
(H&E). Examples of elastin breaks are
indicated by the white arrows. Scale
bars = 25 lm. (b) Collagen quantification
using Sirius Red-positive staining, (c)
number of elastin breaks quantified by
VVG staining, (d) medial cellularity and (e)
aortic wall thickness. Data are
means  SEM. *p < .05 using ANOVA
with Tukey post-test (n = 4–9 mice)
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2004). Indeed, PolG mice show extensive mtDNA damage and
reduced mitochondrial respiration in their aortas and cultured
VSMCs, with no change in ROS early in life (Yu et al., 2013). PolG
mice showed multiple features of progeria, including kyphosis and
greying of fur, and became too frail to survive instrumentation
beyond 32 wk; we therefore examined vascular aging markers
between 8 and 32 wk of age in both WT and PolG mice. In addition,
PolG mice had significantly lower body weights particularly at later
time points; we therefore compared all measurements against 8-wk-
old mice in each group to avoid systemic confounders. PolG mice
showed no significant changes in pulse pressure and aortic PWV
with a minor reduction in heart rate by 32 wk (Figure 6a–c). In con-
trast, there was a marked reduction in carotid artery compliance and
distensibility by 22 wk in PolG mice, and a borderline increase in
b-stiffness index (p = .06), which occurred earlier than in WT mice
(Figure 6d–f). Interestingly, WT mice had increased aortic collagen
by 32 wk, whereas PolG mouse aortas showed no significant
changes, and elastin breaks did not change significantly in either
group over this shorter time course (Figure 6g–h). These data sug-
gest that mitochondrial damage and dysfunction accelerate physio-
logical markers of vascular aging before features of structural aging
are apparent.
(a)
(c)
(e)
(h)
(i) (j)
(f) (g)
(d)
(b)
F IGURE 3 Reductions in vascular
mitochondrial DNA copy number,
mitochondrial protein expression and
mitochondrial respiration with age in mice.
(a) Relative aortic mitochondrial copy
number (mtCN) (n = 4–6 mice), (b) relative
aortic mtDNA lesions, (c–g) Western blots
showing protein levels of the major mtCN
regulators Twinkle, PGC1a or TFAM with
their respective quantifications (relative to
b-actin), (h) relative protein expression
levels of mitochondrial complexes (I–V
relative to citrate synthase levels)
quantified from Western blot, (i) Seahorse
oxygen consumption rate (OCR) in intact
aortas indicating injection points (grey
dotted lines) of oligomycin (O), FCCP (F),
antimycin A and rotenone (A/R) and (j)
quantified baseline OCR (n = 3 aortas per
group). Data are means  SEM. *p < .05
using ANOVA with Tukey post-test
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3 | DISCUSSION
Aging represents the largest risk factor for the development of cardio-
vascular disease, identifying an important need for accurate tech-
niques and parameters in vascular aging research. We studied how
and when vascular aging develops in mice, and how manipulations to
mtDNA and mitochondrial function affect vascular aging. There are a
number of important findings in our study. First, we show that vascular
aging in mice can be demonstrated by changes in a variety of physio-
logical parameters, with multiple robust reproducible markers appear-
ing as early as 44 wk. These parameters recapitulate those in humans,
although their sensitivity to detect aging differs. Our study provides
standardized early and reproducible time points, methods and physio-
logical parameters to study vascular aging in mice. Second, we show
that mouse vascular aging is associated with characteristic structural
changes over the same time, confirming that these changes in physio-
logical parameters represent structural changes associated with aging.
Third, we show that mtCN, the proteins that regulate mtCN, and mito-
chondrial respiration are all reduced at the same age that changes in
functional and structural parameters were observed. Finally, using
gain- and loss-of-mitochondrial-function mouse models, we identify
that mtCN and mtDNA integrity directly regulate the onset and pro-
gression of vascular aging in mice. The time course of changes in vas-
cular aging markers and mitochondrial CN, DNA damage, regulatory
protein expression and function are summarized in Figure 7.
Improved animal welfare means that laboratory mice can now live
more than 2 years. This complicates aging research as age-associated
multi-organ pathologies can render such aged mice too frail for func-
tional analyses, and makes aging studies very long and expensive to
perform. There is also little consensus as to when mice develop the
earliest signs of aging. Using a range of five different ages and multiple
physiological parameters, we identify an age window for the onset of
vascular aging between 32 and 44 wk of age. These physiological
changes occurred concurrent with changes in vascular structure that
are characteristic of aging, including collagen accumulation, elastin
breaks, reduced medial cellularity and vessel wall thickening. This age
window is far earlier than previously described and allows for far
shorter vascular aging protocols. Our study also addresses the causes
vs. the consequences of vascular aging, for example whether vascular
stiffening precedes or follows pulse pressure changes, a subject of
recent debate (Humphrey et al., 2016). Changes in arterial compliance,
distensibility, b-stiffness index and PWV as well as structural changes
were all present before changes in pulse pressure appeared, suggest-
ing that increased pulse pressure is a consequence rather than a cause
of vessel stiffening, at least at early time points in mice.
The role of mitochondrial dysfunction and ROS in aging remains
controversial. The prevailing view has been that mitochondrial dam-
age and dysfunction both occur in multiple tissues in aging and pro-
mote aging, possibly through ROS accumulation and oxidative
damage. However, reduced mitochondrial respiration can result in
(a)
(d)
(g) (h)
(e) (f)
(b) (c)
F IGURE 4 Tw+ mice have increased
vascular mtCN and enhanced
mitochondrial respiration. (a) qPCR for
Twinkle mRNA (n = 3), (b–c) Western blot
for Twinkle protein in aortas of WT and
Tw+ mice at 44 wk (n = 3–4), (d)
mitochondrial copy number (mtCN) in
aorta in WT and Tw+ mice at 44 and
72 wk (n = 5–6), (e–f) representative
Western blot of mitochondrial complexes
(I–V) in aortas from 72-wk-old WT and
Tw+ mice with quantified levels relative to
citrate synthase (CS) (n = 3–5), (g)
Seahorse profile of WT and Tw+ mouse
aortas at 44 wk indicating injection of the
compounds (grey dotted lines) oligomycin
(O), FCCP (F) and antimycin A and
rotenone (A/R), with (h) Quantification of
OCR at baseline and after addition of the
uncoupler FCCP (n = 2 aortas). WT (grey
labels); Tw+ (blue labels). Data are
means  SEM. *p < .05 using ANOVA
with Tukey post-test
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normal or greater lifespan, such as mice heterozygous for the myosin
light chain kinase gene (mlck1), the penultimate enzyme in ubiqui-
none biosynthesis, despite reduced ATP synthesis and increased
mitochondrial ROS production (Hekimi, 2013). In addition, mt-Dele-
tor mice (which have mutant Twinkle) have large–scale mitochondrial
deletions and reduced respiratory function in some tissues late in
life, but a normal lifespan (Tyynismaa et al., 2004). Furthermore,
some studies show that antioxidant therapies do not improve lifes-
pan despite reducing ROS (Perez et al., 2009), and some Caenorhab-
ditis elegans respiratory chain mutants show increased superoxide
generation but have increased rather than decreased longevity (Feng,
Bussiere & Hekimi, 2001; Yang & Hekimi, 2010). Similar
observations from Drosophila melanogaster, C. elegans and yeast (re-
viewed in Wang & Hekimi, 2015) suggest that the pathways con-
necting mtDNA damage, respiratory dysfunction, ROS and aging are
more complex than previously suggested.
To dissect the role of mtDNA-mediated mitochondrial dysfunc-
tion in vascular aging, we examined mice with specific mtDNA
manipulations that do not change vascular ROS at the time points
studied (Yu et al., 2013, 2017). Both mtCN and mitochondrial respi-
ration were reduced markedly by 44 wk in WT mice, concurrent
with physiological and structural markers of vascular aging. Multiple
markers of vascular aging were delayed in Tw+ mice or accelerated
in PolG mice, indicating that manipulations that change
(a) (b)
(c) (d)
(e) (f)
(g) (h)
F IGURE 5 Tw+ mice have delayed
vascular aging. (a–f) Pulse pressure, heart
rate, aortic pulse wave velocity (PWV), and
carotid artery compliance, carotid artery
distensibility and carotid b-stiffness index
in WT and Tw+ mice aged 22–72 wk
(n = 6–9), (g) representative images of
aorta from 44-wk-old WT and Tw+ mice
stained with Sirius Red and quantification
of the percentage positive staining (scale
bar = 50 lm) and (h) representative images
of aorta from 44-wk-old WT and Tw+ mice
stained with Verhoeff–van Gieson (VVG)
showing elastin breaks (white arrows) and
quantification of the number of elastin
breaks. Scale bar = 20 lm (n = 3–7). WT
(grey labels); Tw+ (blue labels). Data are
means  SEM. *p < .05 using ANOVA
with Tukey post-test
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mitochondrial respiration can regulate vascular aging independent of
ROS, at least at early time points, and that mitochondrial respiration
has direct regulatory effects on the rate of vascular aging. Our data
suggest that the protective effect of Tw overexpression may be
related to an enhanced mtCN regulation, mitochondrial biogenesis
and improved autophagy.
The mechanisms responsible for the mtCN decline in aging are
poorly understood. The minimal mtDNA replication machinery com-
prises PolG, mtSSB and Twinkle (Korhonen, Pham, Pellegrini &
Falkenberg, 2004). Although PolG defects cause mtDNA damage,
PolG alone cannot replicate mtDNA (Korhonen et al., 2004), and
PolG overexpression does not increase mtCN in cell lines (Schultz
et al., 1998). In contrast, mtSSB mRNA expression parallels mtDNA
abundance in mammalian tissues and is upregulated with mitochon-
drial biogenesis (Schultz et al., 1998). TFAM and Twinkle are the
two main regulators of mtCN, which is directly proportional to
expression levels of both proteins (Ekstrand et al., 2004; Tyynismaa
et al., 2004). TFAM also stabilizes the nucleoid structure of mtDNA
and initiates replication (Kaufman et al., 2007). We find a marked
reduction in mtCN, expression of TFAM, Twinkle and PGC1a, and
mitochondrial respiratory complexes at 44 wk. Remarkably, despite
this reduction at 44 wk, TFAM, Twinkle and PGC1a increased again
by 72 wk, which may be a compensatory mechanism to recover
mtCN levels, albeit insufficient to restore mtCN and respiratory
function. Similar reductions in mtCN and compensatory responses
have been shown in mouse glial neurons at 40–52 wk of age
(a) (b)
(c) (d)
(e) (f)
(g) (h)
F IGURE 6 PolG mice have accelerated
vascular aging. (a–f) Pulse pressure, heart
rate, aortic pulse wave velocity (PWV) and
carotid artery compliance, carotid
distensibility and carotid b-stiffness index
in WT and PolG mice aged 8–32 wk
relative to 8-wk-old mice (n = 5–9), (g)
representative images of aortas from 22-
wk-old WT and PolG mice stained with
Sirius Red and quantification of positive
staining (scale bar = 50 lm) and (h)
representative images of aortas from 8-wk-
old WT and PolG mice stained with
Verhoeff–van Gieson (VVG) for measuring
elastin breaks (scale bar = 20 lm) (n = 4–
6). WT (grey labels); PolG (red labels). Data
are means  SEM. *p < .05 using ANOVA
with Tukey post-test
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(Stauch, Purnell & Fox, 2014) or rat brain (Picca et al., 2013). Inter-
estingly, TFAM, Twinkle and PGC1a are all nuclear-encoded, as is
complex II, which was the only complex to have significantly
enhanced levels from 44 to 72 wk, suggesting that the nuclear gen-
ome may increase proteins necessary for enhancing mtCN to recover
mitochondrial function, but that these are insufficient to increase
mtCN or rescue the respiratory deficit.
Our study has a number of limitations. First, it is possible that
PolG and Tw+ mice do not recapitulate the same mechanisms that
accelerate or protect against loss of mitochondrial function seen in
normal aging, respectively. In particular, the rate at which mtDNA
mutations reach phenotypic expression differs markedly among tis-
sues (Vermulst et al., 2008) and vessels might be protected from
these manipulations. However, aging at/after 44 wk was associated
with a marked reduction in mtCN and mitochondrial respiration,
while Tw+ mice maintained mtCN and respiration at 44 and 72 wk
to levels seen in younger mice. Second, the cause of reduced mtCN
with age is not known, but our data suggest reductions in Twinkle
and TFAM and the upstream regulator PGC1a are important contrib-
utors. However, despite the compensatory rise in PGC1a, TFAM and
Twinkle at 72 wk, it appears that age-related mtCN depletion
becomes irreversible. Our data also do not prove that reduced mtCN
directly reduces mitochondrial respiration. However, there was a
reduction in mitochondrial OCR with no change in ECAR with
increasing age associated with reduced mtCN, and Tw+ mice showed
increased mtCN and increased respiration, suggesting a causal
relationship. Third, the models used regulate mtDNA replication and
replicative proofreading primarily and may have systemic effects that
might affect vascular physiological parameters; however, there were
no changes in heart rate or mean systolic or diastolic blood pres-
sures in Tw+ or PolG mice, particularly at time points when changes
in vascular physiological parameters were first apparent. Fourth, our
assays were performed on whole arteries and we have not deter-
mined which cell type(s) in the vessel wall is/are primarily responsi-
ble for the multiple physiological and structural changes observed.
However, VSMCs comprise the bulk of the mouse artery and syn-
thesize collagen and elastin; it is therefore likely that VSMCs are
responsible for the reduced mtCN and respiration as well as changes
in passive physiological parameters and vascular structure. Further-
more, other studies suggest that mice do not develop EC dysfunc-
tion over the time course used in our study (Modrick, Kinzenbaw,
Chu, Sigmund & Faraci, 2012). Finally, some of the changes observed
appear small, and their biological significance as risk factors for car-
diovascular disease is unproven; however, the 1.3-fold reduction in
compliance and distensibility, 1.5-fold increase in b-stiffness index
and 1.3-fold increase in PWV are similar to changes seen in human
aging (reviewed in Vlachopoulos et al., 2010).
In summary, we have identified standardized time points and a
combination of biologically coherent physiological parameters to
measure vascular aging in mice, and show that the first physiological
and structural changes are apparent by 44 wk. Reduced mitochon-
drial respiration is not only present as mouse arteries age, but
F IGURE 7 Changes in WT, Tw+ and PolG mice during vascular aging. Summary of the age at which changes are first observed over
8–72 wk of age in WT, Tw+ and PolG mice. mtDNA, mitochondrial DNA; mtCN, mitochondrial copy number; PWV, pulse wave velocity
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manipulations that result in increased or decreased respiration delay
or accelerate changes associated with aging, respectively. Our data
highlight the importance of mitochondrial function in vessel aging,
provide novel insight into the interaction between mtCN and mito-
chondrial respiration and illustrate the importance of preserving the
mitochondrial genome to maintain healthy vessel aging.
4 | EXPERIMENTAL PROCEDURES
4.1 | Animals
This research was regulated under the Animals (Scientific Proce-
dures) Act 1986 Amendment Regulations 2012 following ethical
review by Cambridge University Animal Welfare and Ethical Review
Body (AWERB). Homozygous knock-in PolG mutation or heterozy-
gous Twinkle overexpression mice have been described previously
(Trifunovic et al., 2004; Tyynismaa et al., 2004). Male and female
mice aged 8, 22, 44 or 72 wk (including 32 wk for PolG) were stud-
ied with age-matched WT littermate controls used for each strain.
Animals were provided chow diet and water ad libitum and main-
tained under a 12:12-hr light–dark cycle.
4.2 | Imaging and blood pressure measurements
Where possible, the experimenter was blinded to mouse genotype,
and WT controls and transgenic mice were always studied on the
same day. Mice were anaesthetized with inhaled isoflurane (2.5% in
1.5 L/min O2; maintained at 1.5%) and placed supine on a heated plat-
form. Right common carotid artery (RCCA) M-mode vascular diame-
ters and pulsed Doppler velocities were obtained at an angle of 50–
59° using a 30-MHz probe (Vevo 770; Fujifilm VisualSonics, Amster-
dam, The Netherlands). Immediately following imaging, the RCCA was
cannulated with 1.2F blood pressure catheter (Transonic Scisense Inc,
Ontario, Canada). Combined RCCA measurements and blood pressure
generated functional indices of vascular aging including the following:
1. Compliance = Ds–Dd/Ps–Pd
2. b-Stiffness Index = lnPs–Pd/[(Ds–Dd)/Dd]
3. Distensibility = (Ds–Dd)/(Dd*Ps–Pd)
where Ds is systolic diameter, Dd is diastolic diameter, Ps is systolic
pressure, Pd is diastolic pressure and ln is the natural log (Figure S1).
Pulse wave velocity was measured by inserting a dual-sensor
catheter (1.2F; Transonic Scisense Inc, Ontario, Canada) via the left
femoral artery to record blood pressure from the thoracic and
abdominal aorta simultaneously (Figure S2). PWV was calculated as
the distance between the pressure sensors (30 mm)/average transit
time for pressure wave between sensors over 10 waves using Lab-
Scribe2 software (iWorx Systems Inc, Dover, NH). All blood pressure
measurements were recorded for 10 min to reach steady state with
body temperature maintained at 37.0  0.2°C. Animals were sacri-
ficed by CO2 inhalation and cervical dislocation, with subsequent
rapid snap-freezing of aortic tissue.
4.3 | Histochemistry and Immunohistochemistry
Five-micrometre transverse aorta sections were stained with Sirius
Red to assess collagen expression, Verhoeff–van Gieson (VVG) for
elastin integrity, or haematoxylin and eosin (H&E) for cellularity and
wall thickness. Antibodies for inflammatory markers were IL-1b
(1:200; ab9722; Abcam, UK) and VCAM-1 (1:1000; ab134047;
Abcam, UK) and MAC3 (1:400; 553322; BD). In Sirius Red sections,
five random evenly distributed areas were photographed at 4009
magnification using a bright-field microscope and imaging software
(Image-Pro Insight 9.1, Media Cybernetics, MD, USA). The arterial
media was delineated and the percentage of media positive for red
staining assessed by thresholding using ImageJ software (National
Institutes of Health, MD, USA), and averaged over the five areas.
VVG-stained sections were examined at 2009 and 4009 and elastin
breaks defined as a disruption in the continuity of the lamina where
both ends of the break were visible. H&E sections were pho-
tographed at 1009 and medial cellularity determined as number of
nuclei/area. Wall thickness was measured as distance between the
lumen and external elastic lamina at five random points using ImageJ
(NIH, MD, USA). Inflammatory markers were quantified by counting
the total DAB-positive staining relative to total cells using ImageJ
(NIH, MD, USA).
4.4 | Relative mitochondrial copy number
Abdominal aorta mtCN was estimated by qPCR on total DNA
extracted using the DNeasy Blood and Tissue Kit (Qiagen Ltd, UK).
Primer sequences for the mitochondrial segment were as follows: (F)
GCCAGCCTGACCCATAGCCATAAT and (R) GCCGGCTGCGTATTC-
TACGTTA. Primer sequences for the single-copy nuclear control
were as follows: (F) TTGAGACTGTGATTGGCAATGCCT and (R)
CCAGAAATGCTGGGCGCTCACT. mtCN was calculated relative to
nuclear DNA using the following equations:
1. DCT = mitochondrial CT – nuclear CT
2. Relative mitochondrial DNA content = 2 9 2DCT
4.5 | Mitochondrial DNA damage and common
deletion assay
Long and short mitochondrial segments were amplified from 15 ng total
DNA using the Long Amplification Taq Polymerase kit (Takara Bio Inc,
Kusatsu, Japan). Long-mitochondrial-segment (10.06 kb) primer
sequences were as follows: (F) GCCAGCCTGACCCATAGCCATAAT
and (R) GAGAGATTTTATGGGTGTAATGCGG. Short-mitochondrial-
segment (117 bp) primer sequences were as follows: (F) GCCAGCCT-
GACCCATAGCCATAAT and (R) GCCGGCTGCGTATTCTACGTTA. All
reactions were heat-started at 70°C for 3 min before addition of the
Taq polymerase. Long-segment conditions were as follows: 16 cycles of
(94°C for 15 s; 64°C for 12 min) with a final extension step of 72°C for
10 min. Short-segment conditions were as follows: 23 cycles of (94°C
for 30 s; 64°C for 45 s; 72°C for 45 s) with a final extension step of
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72°C for 10 min. Samples were run on a 0.8% agarose gel to confirm
product size only. The quantification of the samples was performed
using PicoGreen labelling according to the manufacturer’s protocol and
using dilutions of known k DNA standards to generate a standard curve
(Thermo Fisher Scientific, UK). Fluorescence measurements were
assessed using a microplate reader at an excitation of 485 nm and emis-
sion of 528 nm and were corrected for background by subtracting the
fluorescence from a blank no-template control. Long- and short-seg-
ment reactions were stopped in the linear phase, and this was con-
firmed by running controls containing 50% of the starting undamaged
template DNA which resulted in 40%–60% of the amplification. Long-
segment amplification was normalized to the short segment to account
for changes in mtCN, and the estimated relative number of lesions cal-
culated using the following formula based on the zero-class Poisson
expression as described previously (Furda, Santos, Meyer & Van Hou-
ten, 2014): Lesion Frequency = ln (AD/AC), where AD is the amplifica-
tion of the unknown sample and AC is the amplification of an
undamaged control. The mouse equivalent of the common 4977-bp
deletion in humans was also assessed using qPCR as described previ-
ously (Mercer et al., 2010).
4.6 | Western blotting
Frozen mouse thoracic aortas were homogenized by manual crushing
with a pestle, and then high-speed bead shaking (TissueLyser LT; Qia-
gen Ltd, UK) in RIPA lysis buffer supplemented with protease inhibi-
tors followed by sonication. 15 lg protein was loaded into a 4%–12%
gradient gel and detected with the following antibodies: Twinkle
(1:1000; Aviva Systems Biology, CA, USA), TFAM (1:500; Proteintech,
IL, USA), PGC1a (1:1000; Abcam, UK), Total OXPHOS cocktail (1:500;
ab110413; Abcam, UK), p62 (1:1000; Abcam, UK), Citrate Synthase
(1:1000; ab96600; Abcam, UK) and b-actin (1:5000; Sigma-Aldrich,
UK). Citrate synthase was selected as a loading control for respiratory
complexes as it is mitochondrion-specific and the expression did not
change with age (further confirmed with b-actin). Protein bands were
labelled with Amersham ECL horseradish peroxidase-conjugated sec-
ondary antibodies (GE Healthcare Life Sciences, UK) and band density
quantified using ImageJ software (NIH, MD, USA).
4.7 | Seahorse assay
Thoracic aortas were freshly harvested, dissected free of surrounding
fat tissue and cut into five rings each weighing approximately
500 lg. Each ring was secured into wells of an XFe24 islet capture
microplate using the mesh rings provided, washed once with bicar-
bonate-free DMEM (Sigma-Aldrich, UK) and run in a Seahorse
XFe24 Extracellular Flux Bioanalyzer (Agilent Technologies, CA,
USA). Mitochondrial respiratory complex inhibitors and the uncou-
pler FCCP were prepared for automated injection at final concentra-
tions of 10 lg/ml oligomycin A, 1 lmol/L FCCP, 10 lmol/L
antimycin A and 10 lmol/L rotenone. OCR and ECAR were mea-
sured at baseline and after the inhibitor addition, and data were nor-
malized to individual tissue weights.
4.8 | qPCR
RNA was extracted from whole aortas using the miRNeasy Mini Kit
(Qiagen Ltd, UK) and cDNA synthesized from 1 lg of RNA using the
Omniscript Reverse Transcription Kit (Qiagen Ltd, UK). 20 ng cDNA
was used with 1X Rotor-Gene SYBR Green PCR Kit (Qiagen Ltd,
UK) and 0.5 lM primers in a final reaction volume of 20 ll. Cycle
conditions were 95°C for 5 min, followed by 40 cycles of 95°C for
5 s and 60°C for 10 s. Primer sequences were as follows: Twinkle (F)
GCCACGTGACTCTGGTCATTC and (R) CCATCAAAGCGATTCTTG-
GACA; TFAM (F) CAAGTCAGCTGATGGGTATGG and (R)
TTTCCCTGAGCCGAATCATCC; and b-actin (F) GGCACCACACCTTC-
TACAATG and (R) GTGGTGGTGAAGCTGTAGCC. Relative gene
expression was calculated using the 2-DDCt method.
4.9 | Statistical analysis
Data were assessed for normal distribution using the D’Agostino–
Pearson or Shapiro–Wilk normality test in GraphPad Prism Software
7 (GraphPad Software Inc, CA, USA). All data were analysed using
either a Student’s unpaired t test or multiple comparisons ANOVA
with Tukey post-tests. All data are expressed as mean  SEM. Data
represent mouse numbers or independent experiments. Statistical
significance was accepted as p < .05.
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